ALS2CL
protein-codingALS2 C-terminal like, the group of VPS9 domain containing|Dbl family Rho GEFs
Gene summary
Predicted to enable guanyl-nucleotide exchange factor activity and small GTPase binding activity. Predicted to be involved in endosomal transport. Predicted to act upstream of or within intracellular protein localization. Predicted to be located in cytosol. Predicted to be active in cytoplasmic vesicle. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Evidence or clinical applicability is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALS2CL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_147129.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 9 | 11 | |||
| missense | 150 | 11 | 161 | |||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 0 | 158 | 21 | 0 | 179 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_667340.2 | 25 | MANE Select | |
| Ensembl | ENSP00000313670.4 | 25 | MANE Select | |
| RefSeq | NP_001177636.1 | 25 | Standard | |
| Ensembl | ENSP00000413223.1 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Rab regulation of trafficking
- RAB GEFs exchange GTP for GDP on RABs
Biological Process
- endosome organization
- positive regulation of GTPase activity
Molecular Function
- GTPase activator activity
- Rab guanyl-nucleotide exchange factor activity
- identical protein binding
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318962
- Coding exons
- 25
- Length
- 24708
- Individuals with no LoFs
- 125023
- Homozygous LoFs
- 4
- Heterozygous LoFs
- 720
- Defined
- 125747
- p
- 0.00288
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.169 | 553 | 564 | 0.980 | 0.0000354 | 6110 |
| Missense (PolyPhen) | 152 | 178.1 | 0.85344 | 2030 | ||
| Synonymous | 0.649 | 241 | 254 | 0.948 | 0.0000167 | 1922 |
| Loss of Function | 1.04 | 47 | 55.4 | 0.849 | 0.00000271 | 597 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.0021 | 0.0021 | notable |
| Ashkenazi Jewish | 0.0012 | 0.0012 | notable |
| East Asian | 0.0030 | 0.0030 | notable |
| Finnish | 0.0049 | 0.0049 | notable |
| European (Non-Finnish) | 0.0028 | 0.0028 | notable |
| South Asian | 0.0043 | 0.0043 | notable |
| Other | 0.0043 | 0.0042 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a guanine nucleotide exchange factor (GEF) for Rab5 GTPase. Regulates the ALS2-mediated endosome dynamics. {ECO:0000269|PubMed:15388334, ECO:0000269|PubMed:16473597, ECO:0000269|PubMed:17239822}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.956
- RVIS EVS
- -0.92
- RVIS percentile EVS
- 9.81
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.654
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |